The molecular mechanism of human group IIA phospholipase A2 inactivation by bolinaquinone

Journal of Molecular Recognition

Volumn 22, Issue 6, 2009, Pages 530-537

  Monti, Maria Chiara ^a   Chini, Maria Giovanna ^a   Margarucci, Luigi ^a   Tosco, Alessandra ^a   Riccio, Raffaele ^a   Bifulco, Giuseppe ^a   Casapullo, Agostino ^a  

^a UNIVERSITY OF SALERNO   (Italy)

Author keywords

Docking; Enzyme inactivation; Ligand protein interactions; Marine natural products; Mass spectrometry; Phospholipase A2; Surface plasmon resonance

Indexed keywords

BACTERIA (MICROORGANISMS);

EID: 70349932443     PISSN: 09523499     EISSN: 10991352     Source Type: Journal    
DOI: 10.1002/jmr.968     Document Type: Article

References (45)

1. Aquino M, Guerrero MD, Bruno I, Terencio MC, Payà M, Riccio R. 2008. Development of a second generation of inhibitors of microsomal prostaglandin E synthase 1 expression bearing the gammahydroxybutenolide scaffold. Bioorg. Med. Chem. 16:9056-9064
2. Balsinde J, Balboa M,Insel P, Dennis E. 1999. Regulation and inhibition of phospholipase A2. Annu. Rev. Pharmacol. Toxicol. 39:175-189
3. Berg OG, Yu BZ, Rogers J, Jain MK. 1991. Interfacial catalysis by phospholipase A2: determination of the interfacial kinetic rate constants. Biochemistry 30:7283-7297
4. Breneman CM, Wiberg KB. 1990. Determining atom-centered monopoles from molecular electrostatic potentials. The need for high sampling density in formamide conformational analysis. J. Comput. Chem. 11:361-373
5. Busserolles J, Payá M, D'Auria MV, Gomez-Paloma L, Alcaraz MJ. 2005. Protection against 2, 4, 6-trinitrobenzenesulphonic acid-induced colonic inflammation in mice by the marine products bolinaquinone and petrosaspongiolide. Biochem. Pharmacol. 69:1433-1440
6. Coop BR, Ireland C, Barrows L. 1991. Wakayin: a novel cytotoxic pyrroloiminoquinone alkaloid from the ascidian Clavelina species. J. Org. Chem. 56:4596-4597
7. Dal Piaz F, Casapullo A, Randazzo A, Riccio R, Pucci P, Marino G, Gomez- Paloma L. 2002. Molecular basis of phospholipase A2 inhibition by petrosaspongiolide. ChemBioChem. 3:664-671
8. De Guzman F, Coop B, Mayne C, Conception G, Mangalindan G, Barrows L, Ireland C. 1998. Bolinaquinone: a novel cytotoxic sesquiterpene hydroxyquinone from a philippine Dysidea sponge. J. Org. Chem. 63:8042-8044
9. Di Micco S, Terracciano S, Bruno I, Rodriquez M, Riccio R, Taddei M, Bifulco G. 2008. Molecular modeling studies toward the structural optimization of new cyclopeptide-based HDAC inhibitors modeled on the natural product FR235222. Bioorg. Med. Chem. 16:8635-8642
10. Forster S, Ilderton E, Norris JFB, Summerly R, Yardley HJ. 1985. Characterization and activity of phospholipase A2 in normal human epidermis and in lesion-free epidermis of patients with psoriasis or eczema. Br. J. Dermatol. 27:112-135
11. Frisch MJ, Trucks GW, Schlegel HB, Scuseria GE, Robb MA, Cheeseman JR, Montgomery JA Jr, Vreven T, Kudin KN, Burant JC, Millam JM, Iyengar SS, Tomasi J, Barone V, Mennucci B, Cossi M, Scalmani G, Rega N, Petersson GA, Nakatsuji H, Hada M, Ehara M, Toyota K, Fukuda R, Hasegawa J, Ishida M, Nakajim T, Honda Y, Kitao O, Nakai H, Klene M, Li X, Knox JE, Hratchian HP, Cross JB, Bakken V, Adamo C, Jaramillo J, Gomperts R, Stratmann RE, Yazyev O, Austin AJ, Cammi R, Pomelli C, Ochterski JW, Ayala PY, Morokuma K, Voth GA, Salvador P, Dannenberg JJ, Zakrzewski VG, Dapprich S, Daniels AD, Strain MC, Farkas O, Malick DK, Rabuck AD, Raghavachari K, Foresman JB, Ortiz JV, Cui Q, Baboul AG, Clifford S, Cioslowski J, Stefanov BB, Liu G, Liashenko A, Piskorz P, Komaromi I, Martin RL, Fox DJ, Keith T, Al-Laham MA, Peng CY, Nanayakkara A, Challacombe M, Gill PMW, Johnson B, Chen W, Wong MW, Gonzalez C, Pople JA. 2004. Gaussian 03, Revision E.01. Gaussian, Inc., Wallingford CT.
12. Giannini C, Debitus C, Lucas R, Ubeda A, Payà M, Hooper J, D'Auria MV. 2001. New sesquiterpene derivatives from the sponge Dysidea species with a selective inhibitor profile against human phospholipase A2 and other leukocyte functions. J. Nat. Prod. 64:612-615
13. Gil B, Sanz MJ, Terencio MC, De Giulio A, De Rosa S, Alcaraz MJ, Payà M. 1995. Effects of marine 2-polyprenyl-1, 4-hydroquinones on phospholipase A2 activity and some inflammatory responses. Eur. J. Pharmacol. 285:281-288
14. Glaser KB, Jacobs RS. 1987. Inactivation of bee venom phospholipase A2 by manoalide. A model based on the reactivity of manoalide with amino acids and peptide sequences. Biochem. Pharmacol. 36:2079-2086
15. Glaser KB, De Carvalho M, Jacobs R, Kernan M, Faulkner DJ. 1989. Manoalide: structure-activity studies and definition of the pharmacophore for phospholipase A2 inactivation. Mol. Pharm. 36:782-788
16. Gomez-Paloma L, Monti MC, Terracciano S, Casapullo A, Riccio R. 2005. Chemistry and biology of anti-inflammatory marine natural products. Phospholipase A2 inhibitors. Curr. Org. Chem. 9:1419-1427
17. Guerrero MD, Aquino M, Bruno I, Terencio MC, Payà M, Riccio R, Gomez- Paloma L. 2007. Synthesis and pharmacological evaluation of a selected library of new potential anti-inflammatory agents bearing the gamma-hydroxybutenolide scaffold: a new class of inhibitors of prostanoid production through the selective modulation of microsomal prostaglandin E synthase-1 expression. J. Med. Chem. 50:2176-2184
18. Huey R, Morris GM, Olson AJ, Goodsell DS. 2007. Software news and update a semiempirical free energy force field with charge-based desolvation. J. Comput. Chem. 28:1145-1152
19. Hurt-Camejo E, Camejo G, Peilot H, Oorni K, Kovanen P. 2001. Phospholipase A2 in vascular disease. Circ. Res. 17:298-304
20. Jacobson P, Marshall L, Sung A, Jacobs R. 1990. Inactivation of human synovial fluid phospholipase A2 by the marine natural product, manoalide. Biochem. Pharmacol. 39:1557-1564
21. Jain M, Yu B, Rogers J, Smith A, Booger ET, Ostrander RL, Rheingold A. 1995. Specific competitive inhibitor of secreted phospholipase A2 from berries of Schinus terebinthifolius. Phytochemistry 39:537-547
22. Jimenez M, Cabanes J, Gandia-Herreo F, Escribano J, Garcia-Carmona F, Perez-Gilabert MP. 2003. A continuous spectrophotometric assay for phospholipase A2 activity. Anal. Biochem. 21:131-137
23. Lucas R, Giannini C, D'Auria MV, Payà M. 2003. Modulatory effect of bolinaquinone, a marine sesquiterpenoid, on acute and chronic inflammatory processes. J. Pharmacol. Exp. Ther. 304:1172-1180
24. Maulucci N, Chini MG, Di Micco S, Izzo I, Cafaro E, Russo A, Gallinari P, Paolini C, Nardi MC, Casapullo A, Riccio R, Bifulco G, De Riccardis F. 2007. Molecular insights into azumamide e histone deacetylases inhibitory activity. J. Am. Chem. Soc. 129:3007-3012
25. Mirtti T, Lain VJ, Hiekkanen H, Hurme S, Rowe O, Nevalainen TJ, Kallajoki M, Alanen K. 2009. Group IIA phospholipase A2 as a prognostic marker in prostate cancer: relevance to clinicopathological variables and disease- specific mortality. APMIS 117:151-161
26. Monti MC, Casapullo A, Riccio R, Gomez-Paloma L. 2004a. Further insights on the structural aspects of PLA2 inhibition by gammahydroxybutenolide- containing natural products: a comparative study on petrosaspongiolides M-R. Bioorg. Med. Chem. 12:1467-1474
27. Monti MC, Casapullo A, Riccio R, Gomez-Paloma L. 2004b. PLA2-mediated catalytic activation of its inhibitor 25-acetyl-petrosaspongiolide M: serendipitous identification of a new PLA2 suicide inhibitor. FEBS Lett. 578:269-274
28. Monti MC, Casapullo A, Santomauro C, D'Auria MV, Riccio R, Gomez- Paloma L. 2006. The molecular mechanism of bee venom phospholipase A2 inactivation by bolinaquinone. ChembioChem. 7: 971-980.
29. Monti MC, Casapullo A, Cavasotto CN, Tosco A, Dal Piaz F, Ziemys A, Margarucci L, Riccio R. 2009. The binding mode of petrosaspongiolide M to the human Group IIA phospholipase A2: exploring the role of covalent and noncovalent interactions in the inhibition process. Chem. Eur. J. 15:1155-1163
30. Myszka DG. 2004. Analysis of small molecule interactions using biacore S51 technology. Anal. Biochem. 329:316-323
31. Navalainen TJ, Aho HJ, Eskola JU, Suonpaa AK. 1983. Immunohistochemical localization of phospholipase A2 in human pancreas in acute and chronic pancreatitis. Acta Pathol. Microbiol. Immunol. Scand. 91:97-102
32. Othman R, Baker S, Li Y, Worrall AF, Wilton DC. 1996. Human nonpancreatic (group II) secreted phospholipase A2 expressed from a synthetic gene in Escherichia coli: characterisation of N-terminal mutants. Biochim. Biophys. Acta 1303:92-102
33. Parente L. 2001. Pros and cons of selective inhibition of cyclooxygenase-2 versus dual lipoxygenase/cyclooxygenase inhibition: is two better than one? J. Rheumatol. 28:2375-2382
34. Potts B, Faulkner D, Jacobs R. 1992a. Phospholipase A2 inhibitors from marine organisms. J. Nat. Prod. 55:1701-1717
35. Potts B, Faulkner DJ, Jacobs R. 1992b. Phospholipase A2 inhibitors from marine organisms. J. Am. Chem. Soc. 114:5093-5100
36. Sanner MF. 1999. Python: a programming language for software integrtion and development. J. Mol. Graph. Model. 17:57-61
37. Sanner MF, Olson AJ, Spehner A. 1996. Reduced surface: an efficient way to compute molecular surfaces. Biopolymers 38: 305-320.
38. Schaloske RH, Dennis EA. 2006. The phospholipase A2 superfamily and its group numbering system. Biochem. Biophys. Acta 1761:1246-1259
39. Schuchmann MN, Bothe E, von Sonntag J, von Sonntag C. 1998. Reaction of OH radicals with benzoquinone in aqueous solutions. A pulse radiolysis study. J. Chem. Soc., Perkin Trans. 2:791-796
40. Scott DL, White SP, Browning JL, Rosa JJ, Gelb MH, Sigler PB. 1991. Structures of free and inhibited human secretory phospholipase A2 from inflammatory exudate. Science 254:1007-1010
41. Seilhamer JJ, Pruzanski W, Vadas P, Plant S, Miller JA, Kloss J, Johnson LK. 1989. Cloning and recombinant expression of phospholipase A2 present in rheumatoid arthritic synovial fluid. J. Biol. Chem. 264:5335-5340
42. Soriente A, De Rosa M, Scettri A, Sodano G, Terencio MC, Payà M, Alcaraz MJ. 1999. Manoalide. Curr. Med. Chem. 6:415-431
43. Szabo A, Stolz L, Granzow R. 1995. Surface plasmon resonance and its use in biomolecular interaction analysis (BIA). Curr. Opin. Struct. Biol. 5:699-705
44. Terracciano S, Equino M, Rodriquez M, Monti MC, Casapullo A, Riccio R, Gomez-Paloma L. 2006. Chemistry and biology of anti-inflammatory marine natural products: molecules interfering with cyclooxygenase, NF-kB and other unidentified targets. Curr. Med. Chem. 13: 1947-1969.
45. Vadas P, Pruzanski W. 1986. Role of secretory phospholipases A2 in the pathobiology of disease. Lab. Invest. 55:391-396